EIF4EBP1 and colorectal carcinoma: Furthermore, specific knockdown of YAP1 and pharmacological inhibitor of YAP1 (verteporfin) inhibited the AATs expression and mTOR activation (phospho‐S6 and 4EBP1) in CRC cells and MEFs (Fig. 6F,G).